B

Beam Therapeutics

Develops base editing–based precision medicines

Technical Operations Co-op

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Internship · Winter 2027, Spring 2027Durham, NC, USA$23 - $37 /hr

About the Job

Requirements

  • Be an undergraduate or graduate student pursuing a BS, MS, or PhD in Engineering (Chemical, Biological, or Mechanical) or Biological Sciences (Biochemistry, Biology, Microbiology, or Chemistry, or a related field).
  • Have experience using Microsoft Office applications, including Excel, Word, PowerPoint, and Visio, and retrieving scientific or technical information from digital sources such as databases and scientific literature.
  • Be highly organized and detail-oriented, with strong communication skills and the ability to work effectively in a fast-paced environment.
  • Be currently enrolled in a degree-granting college or university program and maintain student status throughout the duration of the internship.

Responsibilities

  • Develop an understanding of Beam’s gene editing manufacturing equipment, technologies, and processes supporting both hematology and liver programs.
  • Review and verify technical and scientific data included in risk assessments, protocols, and reports to ensure accuracy, completeness, and data integrity in support of project timelines and milestones.
  • Communicate findings, recommendations, and any identified issues from verification activities to cross-functional teams through written summaries, presentations, and verbal updates, supporting timely resolution and project milestones.
  • Support the evaluation and documentation of manufacturing process data, ensuring records are accurate, attributable, legible, and compliant, while identifying potential issues and recommending solutions.

Desired Qualifications

  • Have experience with technical writing and developing presentations to summarize and communicate scientific or technical information.

About the Company

Beam Therapeutics

Develops base editing–based precision medicines

Beam Therapeutics uses base editing to develop precision genetic medicines aimed at correcting disease-causing mutations. It focuses on R&D and collaborates with pharmaceutical companies and research institutions to fund and advance therapies, earning revenue through partnerships, licensing, upfront and milestone payments, and royalties. The company targets genetic disorders such as sickle cell disease with the goal of delivering lifelong cures, differentiating itself through its emphasis on durable genetic remedies and a science-driven, values-led culture.

Company size
501-1,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Beam Therapeutics

See more jobs